Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Phase II Trial of Tremelimumab in Patients with Metastatic Urothelial Cancer Previously Treated with PD-1/PD-L1 Blockade
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG
Study Type: Treatment
Phase: II
NCTID: NCT02684058
Principal Investigator:
Kevin Ginn
A Safety Run-In And Phase II Study Evaluating The Efficacy, Safety, And Impact On The Tumor Microenvironment Of The Combination Of Tocilizumab, Atezolizumab, And Fractionated Stereotactic Radiotherapy In Recurrent Glioblastoma
Study Type: Treatment
Phase: II
NCTID: NCT04729959
Principal Investigator:
Tolga Tuncer
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib NSC 748727 in Newly Diagnosed or Previously Untreated Low-Grade Glioma LGG Not Associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 NF1
Study Type: Treatment
Phase: III
NCTID: NCT04166409
Principal Investigator:
Keith August
A Phase 2 Study of Veliparib ABT-888 and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma HGG without H3 K27M or BRAFV600 Mutations
Study Type: Treatment
Phase: II
NCTID: NCT03581292
Principal Investigator:
Kevin Ginn
Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
Study Type: Supportive Care
Phase: N/A
NCTID: NCT01503086
Principal Investigator:
Keith August
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO
Study Type: Prevention
Phase: II
NCTID: NCT02679144
Principal Investigator:
Kevin Ginn
A Randomized Phase II Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where cisplatin-Based Treatment is Not an Option
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Study Type: Treatment
Phase: III
NCTID: NCT02176967
Principal Investigator:
Keith August
A Phase II, Single-Arm Study of Bempegaldesleukin (Nktr-214) In Combination with Nivolumab In Cisplatin Ineligible, Locally Advanced or Metastatic Urothelial Cancer Patients
Study Type: Treatment
Phase: II
NCTID: NCT03785925
Principal Investigator:
Elizabeth Wulff-Burchfield